Cancer remains a global priority and is still responsible for nearly 10 million deaths a year. WHO has added immune checkpoint inhibitors – powerful therapies that help the immune system target cancer cells, including pembrolizumab, atezolizumab and cemiplimab, for certain metastatic cancers, citing evidence they can extend survival.